BioSpace News Archive

Policy

Ceapro Inc. to Consider Judgements in AVAC Ltd. Actions

Ceapro announced today that Mr. Justice C.M. Jones issued his written decision with respect to the two claims brought by AVAC Ltd. (“AVAC”) in 2011 and 2012 against Ceapro and certain of its wholly owned subsidiaries.

January 29, 2018
·
2 min read
Business

Viemed Announces 2017 Year End Preliminary Financial Results

Viemed announced today that it expects to post final year end December 31, 2017 results on SEDAR by the end of March after the completion of the independent audit.

January 29, 2018
·
7 min read
Policy

Theravance Biopharma and Mylan Announce FDA Acceptance of NDA for Revefenacin (TD-4208) in Adults With COPD

The FDA has assigned a PDUFA target action date of November 13, 2018, and indicated that it does not currently plan to convene an advisory committee meeting to discuss the NDA.

January 29, 2018
·
13 min read
FDA

gammaCore Wins FDA Nod to Treat Acute Pain Associated With Migraine Headache in Adult Patients

This label expansion is the first for electroCore since gammaCore received its initial FDA clearance.

January 29, 2018
·
7 min read
Business

Virginia Tech Carilion Research Institute Partners With INSIGHTEC on Research Program to Develop Treatments for Brain Disorders With Innovative Focused Ultrasound Technology

The research is being led by Stephen LaConte, Ph.D., Associate Professor with the VTCRI and also the Department of Biomedical Engineering and Mechanics in the College of Engineering.

January 29, 2018
·
2 min read
Drug Development

SillaJen Announces First Patient Enrolled in the NCI-Sponsored Trial Evaluating Combination Therapy in Colorectal Cancer with SillaJen’s Pexa-Vec Oncolytic Immunotherapy

Under the CRADA, SillaJen will collaborate with Dr. Greten to evaluate the combination of SillaJen’s lead clinical candidate, Pexa-Vec in combination with durvaluma.

January 29, 2018
·
6 min read
Pharm Country

ISS Recommends Aviragen Stockholders Vote AGAINST the Vaxart Merger on the CAS Group’s BLUE Proxy Card

In reaching its conclusion, ISS performed a detailed review of both sides’ positions in the election contest as well as its own thorough independent analysis.

January 29, 2018
·
9 min read
Business

Insulet Corporation to Announce Fourth Quarter and Full Year 2017 Financial Results on February 21, 2018

Insulet today announced plans to release its financial results for the fourth quarter and full year of 2017 on February 21, 2018 after the close of the financial markets.

January 29, 2018
·
2 min read
U.S. Defense Reports Broad Travelan Reactivity to 180 Pathogenic Bacteria Including Camylobacter and Shigella

The primary goal of this program was to investigate Travelan immunological reactivity with pathogenic bacteria including Campylobacter, Enterotoxigenic Escherichia coli (ETEC) and Shigella.

January 29, 2018
·
5 min read
Business

Ritter Pharmaceuticals Appoints Diane J. Plotkin as Vice President of Clinical Development, Ahead of the Launch of its Phase III Clinical Trial

Dr. Plotkin joins Ritter Pharmaceuticals with nearly thirty years of experience in strategic, global clinical pharmaceutical research involving all phases of drug development.

January 29, 2018
·
3 min read